{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:07:54Z","timestamp":1747285674027},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Inherited primary arrhythmia syndromes are genetically determined disorders of cardiac ion channels or ion channel macromolecular complexes usually associated with a higher risk of sudden cardiac death. These conditions have a very broad spectrum of clinical manifestations, ranging from an asymptomatic course to syncope, atrial and ventricular arrhythmias, and conduction disturbances, but may produce sudden infant death syndrome and unexplained sudden cardiac death in apparently healthy individuals. During the last 20 years, the evolving knowledge on the genetic basis of inherited arrhythmia syndromes has dramatically reshaped our understanding of these conditions and, consequently, had a great impact on patient care. Based on the knowledge of the genetic substrates, specific risk factors for individual genotypes have been identified, and various investigations have been launched with the intention of developing a gene- and even mutation-specific therapy. Preliminary results from animal studies suggest that gene therapy rescues the normal ion channel function and thereby prevents cardiac events in some primary arrhythmia syndromes, which suggests that upon appropriate validation in a clinical setting, it may become available for affected patients. The purpose of this review is to provide clinicians with a contemporary insight into the role of genetic testing in the diagnosis, therapy, and prognosis of patients with primary arrhythmia syndromes, and the clinical implications of screening family members who are at risk of sudden cardiac death.<\/jats:p>","DOI":"10.1097\/crd.0000000000000203","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T23:22:16Z","timestamp":1520810536000},"page":"23-33","source":"Crossref","is-referenced-by-count":14,"title":["Emerging Implications of Genetic Testing in Inherited Primary Arrhythmia Syndromes"],"prefix":"10.1097","volume":"27","author":[{"given":"Babken","family":"Asatryan","sequence":"first","affiliation":[{"name":"From the Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argelia","family":"Medeiros-Domingo","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pcad.2008.06.003","article-title":"Epidemiology of sudden cardiac death: clinical and research implications.","volume":"51","author":"Chugh","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"R3-20230903","first-page":"e60","article-title":"2017 ACC\/AHA\/HRS Guideline for the Evaluation and Management of Patients With Syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"136","author":"Shen","year":"2017","journal-title":"Circulation"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2040622314529325","article-title":"The emerging role of epigenetics in cardiovascular disease.","volume":"5","author":"Abi Khalil","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","article-title":"Long-QT syndrome: from genetics to management.","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome.","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","article-title":"QTc behavior during exercise and genetic testing for the long-QT syndrome.","volume":"124","author":"Schwartz","year":"2011","journal-title":"Circulation"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome.","volume":"348","author":"Priori","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.hrthm.2009.05.021","article-title":"Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.","volume":"6","author":"Kapplinger","year":"2009","journal-title":"Heart Rhythm"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.0000125524.34234.13","article-title":"Compound mutations: a common cause of severe long-QT syndrome.","volume":"109","author":"Westenskow","year":"2004","journal-title":"Circulation"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.112.000091","article-title":"Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years\u2019 experience.","volume":"128","author":"Hofman","year":"2013","journal-title":"Circulation"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/00365510701765643","article-title":"Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.","volume":"68","author":"Berge","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.CIR.99.4.529","article-title":"Low penetrance in the long-QT syndrome: clinical impact.","volume":"99","author":"Priori","year":"1999","journal-title":"Circulation"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00246-010-9821-7","article-title":"Three generations of hereditary long-QT syndrome with complete penetrance caused by the p.G316E KCNQ1 mutation.","volume":"32","author":"Viadero","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jacc.2004.03.043","article-title":"Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan.","volume":"44","author":"Shimizu","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12265-015-9622-8","article-title":"Enhancing the predictive power of mutations in the C-terminus of the KCNQ1-encoded Kv7.1 voltage-gated potassium channel.","volume":"8","author":"Kapplinger","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/eurheartj\/eht089","article-title":"The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy.","volume":"34","author":"Schwartz","year":"2013","journal-title":"Eur Heart J"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng0297-186","article-title":"A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.","volume":"15","author":"Neyroud","year":"1997","journal-title":"Nat Genet"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.102.23.2849","article-title":"Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.","volume":"102","author":"Zhang","year":"2000","journal-title":"Circulation"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCEP.113.000618","article-title":"Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome.","volume":"6","author":"Cuneo","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/01.wnl.0000335760.02995.ca","article-title":"Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy.","volume":"72","author":"Johnson","year":"2009","journal-title":"Neurology"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1161\/CIRCULATIONAHA.110.000620","article-title":"Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2.","volume":"123","author":"Buber","year":"2011","journal-title":"Circulation"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"e005282","DOI":"10.1161\/CIRCEP.117.005282","article-title":"Loss-of-function KCNE2 variants: true monogenic culprits of long-QT syndrome or proarrhythmic variants requiring secondary provocation?","volume":"10","author":"Roberts","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","article-title":"SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.","volume":"80","author":"Wang","year":"1995","journal-title":"Cell"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacc.2005.03.066","article-title":"Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.","volume":"46","author":"Beaufort-Krol","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1073\/pnas.0402546101","article-title":"A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.","volume":"101","author":"Mohler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome.","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype.","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ajhg.2010.04.017","article-title":"Identification of a Kir3.4 mutation in congenital long QT syndrome.","volume":"86","author":"Yang","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.hrthm.2013.07.022","article-title":"The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).","volume":"10","author":"Wang","year":"2013","journal-title":"Heart Rhythm"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCGENETICS.115.001323","article-title":"Spectrum and prevalence of CALM1-, CALM2-, and CALM3-encoded calmodulin variants in long QT syndrome and functional characterization of a novel long QT syndrome-associated calmodulin missense variant, E141G.","volume":"9","author":"Boczek","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","article-title":"Calmodulin mutations associated with recurrent cardiac arrest in infants.","volume":"127","author":"Crotti","year":"2013","journal-title":"Circulation"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.hrthm.2014.10.035","article-title":"CALM3 mutation associated with long QT syndrome.","volume":"12","author":"Reed","year":"2015","journal-title":"Heart Rhythm"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study.","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","article-title":"Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.","volume":"115","author":"Moss","year":"2007","journal-title":"Circulation"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.109.863076","article-title":"Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.","volume":"120","author":"Kapa","year":"2009","journal-title":"Circulation"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCGENETICS.114.000831","article-title":"Enhanced classification of Brugada syndrome-associated and long-QT syndrome-associated genetic variants in the SCN5A-encoded Na(v)1.5 cardiac sodium channel.","volume":"8","author":"Kapplinger","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures.\u201d","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"},{"key":"R48-20230903","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","article-title":"The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.","volume":"113","author":"Schwartz","year":"2006","journal-title":"Circulation"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3.","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge.","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"key":"R51-20230903","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome.","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"R52-20230903","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"R53-20230903","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCEP.111.962027","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"5","author":"Leenhardt","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R54-20230903","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","article-title":"Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.","volume":"3","author":"Tester","year":"2006","journal-title":"Heart Rhythm"},{"key":"R55-20230903","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"R56-20230903","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","article-title":"A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.","volume":"69","author":"Lahat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R57-20230903","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCEP.108.782888","article-title":"Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.","volume":"2","author":"Bai","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R58-20230903","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00246-012-0256-1","article-title":"Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.","volume":"33","author":"Faggioni","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"R59-20230903","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2016.05.004","article-title":"A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.","volume":"13","author":"Gray","year":"2016","journal-title":"Heart Rhythm"},{"key":"R60-20230903","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/hmg\/dds104","article-title":"Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.","volume":"21","author":"Roux-Buisson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R61-20230903","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajhg.2012.08.015","article-title":"Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.","volume":"91","author":"Nyegaard","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R62-20230903","doi-asserted-by":"crossref","first-page":"e004161","DOI":"10.1161\/CIRCEP.116.004161","article-title":"Novel CPVT-associated calmodulin mutation in CALM3 (CALM3-A103V) activates arrhythmogenic Ca waves and sparks.","volume":"9","author":"Gomez-Hurtado","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R63-20230903","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1540-8167.2007.00913.x","article-title":"A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22.","volume":"18","author":"Bhuiyan","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R64-20230903","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.15252\/emmm.201505719","article-title":"TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.","volume":"8","author":"Devalla","year":"2016","journal-title":"EMBO Mol Med"},{"key":"R65-20230903","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCGENETICS.113.000459","article-title":"Novel calmodulin mutations associated with congenital arrhythmia susceptibility.","volume":"7","author":"Makita","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"R66-20230903","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R67-20230903","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features.","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"R69-20230903","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"R70-20230903","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.hrthm.2010.05.036","article-title":"Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands.","volume":"7","author":"van der Werf","year":"2010","journal-title":"Heart Rhythm"},{"key":"R71-20230903","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"R72-20230903","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R73-20230903","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial.","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"R74-20230903","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2006.12.031","article-title":"Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.","volume":"4","author":"B\u00f6kenkamp","year":"2007","journal-title":"Heart Rhythm"},{"key":"R75-20230903","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"R76-20230903","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/CIRCULATIONAHA.113.006901","article-title":"Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.","volume":"129","author":"Denegri","year":"2014","journal-title":"Circulation"},{"key":"R77-20230903","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.117.310882","article-title":"Allele-specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2).","volume":"121","author":"Bongianino","year":"2017","journal-title":"Circ Res"},{"key":"R78-20230903","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge.","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"R79-20230903","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1054\/jelc.2000.18106","article-title":"Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms.","volume":"33","author":"Gussak","year":"2000","journal-title":"J Electrocardiol"},{"key":"R80-20230903","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa071968","article-title":"Sudden cardiac arrest associated with early repolarization.","volume":"358","author":"Ha\u00efssaguerre","year":"2008","journal-title":"N Engl J Med"},{"key":"R81-20230903","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2008.07.052","article-title":"Gender differences in clinical manifestations of Brugada syndrome.","volume":"52","author":"Benito","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R82-20230903","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/HCO.0b013e32831cb920","article-title":"Clinical spectrum of patients with a Brugada ECG.","volume":"24","author":"Fowler","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"R83-20230903","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jhg.2015.97","article-title":"Genetics of Brugada syndrome.","volume":"61","author":"Watanabe","year":"2016","journal-title":"J Hum Genet"},{"key":"R84-20230903","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/humu.9144","article-title":"Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.","volume":"21","author":"Schulze-Bahr","year":"2003","journal-title":"Hum Mutat"},{"key":"R85-20230903","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","article-title":"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.","volume":"60","author":"Crotti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R86-20230903","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm"},{"key":"R87-20230903","first-page":"2260","article-title":"Sodium channel \u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.","volume":"118","author":"Watanabe","year":"2008","journal-title":"J Clin Invest"},{"key":"R88-20230903","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/humu.22328","article-title":"A missense mutation in the sodium channel \u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.","volume":"34","author":"Riur\u00f3","year":"2013","journal-title":"Hum Mutat"},{"key":"R89-20230903","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCGENETICS.108.829192","article-title":"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.","volume":"2","author":"Hu","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R90-20230903","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2014.04.032","article-title":"Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.","volume":"64","author":"Hu","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R91-20230903","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCGENETICS.110.959130","article-title":"MOG1: a new susceptibility gene for Brugada syndrome.","volume":"4","author":"Kattygnarath","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"R92-20230903","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/CIRCULATIONAHA.107.703330","article-title":"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.","volume":"116","author":"London","year":"2007","journal-title":"Circulation"},{"key":"R93-20230903","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/CIRCEP.111.969972","article-title":"A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5.","volume":"5","author":"Ishikawa","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R94-20230903","doi-asserted-by":"crossref","first-page":"e54131","DOI":"10.1371\/journal.pone.0054131","article-title":"Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel.","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"R95-20230903","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","article-title":"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.","volume":"129","author":"Cerrone","year":"2014","journal-title":"Circulation"},{"key":"R96-20230903","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2011.02.021","article-title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.","volume":"8","author":"Giudicessi","year":"2011","journal-title":"Heart Rhythm"},{"key":"R97-20230903","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCEP.110.959619","article-title":"KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation.","volume":"4","author":"Ohno","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R98-20230903","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCEP.107.748103","article-title":"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.","volume":"1","author":"Delp\u00f3n","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R99-20230903","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","article-title":"Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.","volume":"270","author":"Inagaki","year":"1995","journal-title":"Science"},{"key":"R100-20230903","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.hrthm.2010.06.016","article-title":"Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.","volume":"7","author":"Medeiros-Domingo","year":"2010","journal-title":"Heart Rhythm"},{"key":"R101-20230903","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijcard.2013.12.084","article-title":"ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.","volume":"171","author":"Hu","year":"2014","journal-title":"Int J Cardiol"},{"key":"R102-20230903","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jce.12361","article-title":"Gain-of-function KCNH2 mutations in patients with Brugada syndrome.","volume":"25","author":"Wang","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R103-20230903","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.hrthm.2010.08.026","article-title":"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.","volume":"7","author":"Burashnikov","year":"2010","journal-title":"Heart Rhythm"},{"key":"R104-20230903","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"key":"R105-20230903","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/hmg\/ddv036","article-title":"Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome.","volume":"24","author":"Le Scouarnec","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R106-20230903","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities.","volume":"30","author":"Catalano","year":"2009","journal-title":"Eur Heart J"},{"key":"R107-20230903","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2003.04.032","article-title":"Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy.","volume":"95","author":"Peters","year":"2004","journal-title":"Int J Cardiol"},{"key":"R108-20230903","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"R109-20230903","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry.","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation"},{"key":"R110-20230903","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0735-1097(02)01962-9","article-title":"Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.","volume":"40","author":"Smits","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R111-20230903","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry.","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"R112-20230903","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1253\/circj.CJ-10-0445","article-title":"SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.","volume":"74","author":"Nishii","year":"2010","journal-title":"Circ J"},{"key":"R113-20230903","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hrthm.2008.11.009","article-title":"Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.","volume":"6","author":"Meregalli","year":"2009","journal-title":"Heart Rhythm"},{"key":"R114-20230903","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047299","article-title":"Idiopathic short QT interval: a new clinical syndrome?","volume":"94","author":"Gussak","year":"2000","journal-title":"Cardiology"},{"key":"R115-20230903","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome.","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R116-20230903","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/heartjnl-2017-311673","article-title":"Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.","volume":"104","author":"Provid\u00eancia","year":"2018","journal-title":"Heart"},{"key":"R117-20230903","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT syndrome: a familial cause of sudden death.","volume":"108","author":"Gaita","year":"2003","journal-title":"Circulation"},{"key":"R118-20230903","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijcard.2015.04.090","article-title":"Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.","volume":"190","author":"Harrell","year":"2015","journal-title":"Int J Cardiol"},{"key":"R119-20230903","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2010.09.048","article-title":"The short QT syndrome: proposed diagnostic criteria.","volume":"57","author":"Gollob","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R120-20230903","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG.","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"key":"R121-20230903","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/eurheartj\/ehr076","article-title":"Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6).","volume":"32","author":"Templin","year":"2011","journal-title":"Eur Heart J"},{"key":"R122-20230903","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","article-title":"Mutation in the KCNQ1 gene leading to the short QT-interval syndrome.","volume":"109","author":"Bellocq","year":"2004","journal-title":"Circulation"},{"key":"R123-20230903","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.RES.0000162101.76263.8c","article-title":"A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.","volume":"96","author":"Priori","year":"2005","journal-title":"Circ Res"},{"key":"R124-20230903","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1540-8167.2005.40621.x","article-title":"Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.","volume":"16","author":"Hong","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R125-20230903","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome.","volume":"58","author":"Giustetto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R126-20230903","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pcad.2008.10.006","article-title":"Long QT syndrome and short QT syndrome.","volume":"51","author":"Zareba","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"issue":"4 suppl","key":"R127-20230903","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jelectrocard.2005.06.009","article-title":"Short QT syndrome. Genotype-phenotype correlations.","volume":"38","author":"Borggrefe","year":"2005","journal-title":"J Electrocardiol"},{"key":"R128-20230903","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjsports-2015-094827","article-title":"The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes.","volume":"50","author":"Dhutia","year":"2016","journal-title":"Br J Sports Med"},{"key":"R129-20230903","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1973.03220400011003","article-title":"Hereditary progressive atrioventricular conduction defect. A new syndrome?","volume":"225","author":"Lynch","year":"1973","journal-title":"JAMA"},{"key":"R130-20230903","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/12618","article-title":"Cardiac conduction defects associate with mutations in SCN5A.","volume":"23","author":"Schott","year":"1999","journal-title":"Nat Genet"},{"key":"R131-20230903","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1172\/JCI73140","article-title":"A common genetic variant within SCN10A modulates cardiac SCN5A expression.","volume":"124","author":"van den Boogaard","year":"2014","journal-title":"J Clin Invest"},{"key":"R132-20230903","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI38292","article-title":"Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.","volume":"119","author":"Kruse","year":"2009","journal-title":"J Clin Invest"},{"key":"R133-20230903","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCEP.111.967604","article-title":"A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.","volume":"5","author":"Makita","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R134-20230903","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.hrthm.2011.12.006","article-title":"A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.","volume":"9","author":"Hu","year":"2012","journal-title":"Heart Rhythm"},{"key":"R135-20230903","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI19846","article-title":"Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system.","volume":"113","author":"Jay","year":"2004","journal-title":"J Clin Invest"},{"key":"R136-20230903","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cardiores.2007.08.006","article-title":"A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.","volume":"76","author":"Tan","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R137-20230903","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jacc.2003.05.004","article-title":"NKX2.5 mutations in patients with congenital heart disease.","volume":"42","author":"McElhinney","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R138-20230903","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cca.2010.09.035","article-title":"A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death.","volume":"412","author":"Ouyang","year":"2011","journal-title":"Clin Chim Acta"},{"key":"R139-20230903","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng0197-30","article-title":"Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.","volume":"15","author":"Basson","year":"1997","journal-title":"Nat Genet"},{"key":"R140-20230903","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.","volume":"109","author":"Arad","year":"2002","journal-title":"J Clin Invest"},{"key":"R141-20230903","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/europace\/eut291","article-title":"Risk prediction of ventricular arrhythmias and myocardial function in lamin A\/C mutation positive subjects.","volume":"16","author":"Hasselberg","year":"2014","journal-title":"Europace"},{"key":"R142-20230903","first-page":"651","article-title":"High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.","volume":"19","author":"Thevenon","year":"2017","journal-title":"Europace"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00045415-201901000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:23:24Z","timestamp":1693733004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201901000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000203","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}